País: Reino Unido
Idioma: inglés
Fuente: MHRA (Medicines & Healthcare Products Regulatory Agency)
Senna fruit
Reckitt Benckiser Healthcare (UK) Ltd
A06AB06
Senna fruit
7.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01060200; GTIN: 5011417579008 5011417579022 5011417580936
CUSTOMER INFO: Minimum Point Size = 9.00pt N/A N/A N/A N/A N/A N/A N/A N/A BARCODE INFO Barcode Type: Barcode Number: Magnification: Truncated By: Full Height: Bar Height (Smallest Bar): BWR: Encoded Data: Trident Reference No: ZEN Ref: Action: Brand: Category: Segment Group: Segment: Pack Size: Market/Country: Date: Component Code (2D if applicable) : 2 nd Component Code (if applicable) : Parent Technical Packaging Specification: Finished Goods Code: Supply Point: 3rd Party Code Pharmacode No/NE: Edgemark Position: CAD Cam Ref: Printer: Substrate: N/A N/A RB Hull N/A 0000000 Senokot Stimulant Laxative Senna Regular Tablet 100Tablets RB482735 Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only. STUDIO USE ONLY v2.0 Sm•Art check results: Cutter Guides Technical & Non Printing Items Cutter 2 (if applicable) Guides 2 (if applicable) Multi Packaging Solutions (Tewkesbury, UK) Skt-Lft-D8372157-160mmx250mm TR2244996 Paper White UK 23/07/21 A Senthamil Tamilmani 0000000 N/A G=2; O=0; R=0; - ST - 23/07/21 10:55:40 RB Artwork and Print Specification D8372157 Artwork Type: BW Submission 10 mm 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 1 LTH PANTONE 347 C Colours (Leaflet) RBH Contact: Alexander Titmus Connaught House, Connaught Road, Kingswood Business Park, Hull, HU7 3AP, England. T: +44 (0) 1482 828100 UNDER NO CIRCUMSTANCES SHOULD THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION FROM TRIDENT. PACKAGE LEAFLET: INFORMATION FOR THE USER SENOKOT 7.5MG TABLETS 12 YEARS PLUS SENNA FRUIT (PODS) READ THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. • ASK YOUR PHARMACIST IF YOU NEED MORE INFORMATION OR ADVICE. • If any of the side effects get serious or if you notice any side effect not Leer el documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Senokot 7.5 mg Tablets 12 Years Plus 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains powdered Alexandrian Senna fruit (pods) (_Cassia senna _ L._ _(_C. acutifolia _Delile)) and Tinnevelly Senna fruit (pods) (_Cassia _ _angustifolia _Vahl) equivalent to 7.5mg hydroxyanthracene glycosides, calculated as sennoside B. Each tablet also contains 15.82 mg lactose monohydrate For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the short-term relief of occasional constipation 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. The correct individual dose is the smallest required to produce a comfortable soft-formed motion. Adults, the elderly and children over 12 years: Swallow one to two tablets at night Should not be used in children or adolescents under the age of 12 years (see section 4.3). New users should start with the lowest dose and increase it to the maximum dose if necessary. Once regularity has been regained dosage should be reduced and can usually be stopped. If no bowel action has occurred after three days of progressively increased dosage, a medical examination should be considered. Duration of use Not to be used for more than 1 week. Usually it is sufficient to take this medicinal product up to two to three times during that week. If the symptoms persist during the use of the medicinal product, a doctor or a pharmacist should be consulted. See also section 4.4 Special warnings and precautions for use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. Not to be used at the same time as other laxative agents. Cases of intestinal obstructions and stenosis, atony, appendicitis, inflammatory bowel diseases (e.g Crohn’s disease, ulcerative colitis), abdominal pain of unknown origin, severe dehydration state with water and electrolyte depletion Children under 12 years of age. 4.4 SPECIAL WARNINGS Leer el documento completo